IU School of Medicine to spend $20M to launch regenerative medicine center
The center aims to develop new treatments for diabetes, severe wounds, and damage to tissues and organs caused by age, disease or trauma.
Cancer
Articles
China cuts red tape, increases potential for breakthrough medicines
After decades of being starved of innovative treatments for serious conditions like cancer, diabetes and kidney disease, China’s 1.4 billion people are becoming a prime target for Eli Lilly and other pharmaceutical companies.
IU aims to find cures for three forms of cancer, help prevent or slow other diseases
The university said it has hired 33 research faculty to help under the “Grand Challenges” program in precision health, an initiative it rolled out two years ago.
UPDATE: Eli Lilly buying immuno-oncology company for $1.6 billion
The Indianapolis-based pharmaceutical giant said it plans to acquire ARMO BioSciences Inc., which is working on treatments that activate the immune system of cancer patients to recognize and eradicate tumors.
Lilly rolls out its first-ever TV campaign for a cancer drug
The ads for the metastatic breast cancer drug Verzenio show women in their 50s and 60s looking resolute and indomitable, surrounded by smiling friends and family.
IU Health plans $55M cancer center on North Hospital campus in Carmel
The Indianapolis-based health system will present details Tuesday to the Carmel Plan Commission for the two-story, 88,000-square-foot building.
House panel approves bill to raise state smoking age from 18 to 21
Lawmakers stripped a provision from the bill that would have boosted the cigarette tax from 99 cents a pack to $2.99.
IU Health expands specialty cancer program into new facility
The program is for patients with Stage 3 or Stage 4 cancer who had not had success with traditional treatments. Under the program, scientists analyze patients’ genome, leading to a personalized treatment plan.
Blood test to detect 8 cancers early gives promising results
Scientists are reporting progress on a blood test to detect many types of cancer at an early stage, including some of the most deadly ones that lack screening tools.
West Lafayette biotech raises $40M to develop cancer-imaging drugs
The company said the funds would help it test its lead compound in late-stage clinical trials, allowing surgeons to detect cancerous cells with the help of fluorescent dyes.
Struggling Endocyte spending millions for rights to prostate-cancer drug
After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
FDA approves Lilly drug for common advanced breast cancer
U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.
IU, Purdue get $2.55M to study breast cancer
Researchers at Indiana University and Purdue University have received $2.55 million from Susan G. Komen to study possible new treatments.
Lilly breast cancer drug results could challenge Pfizer pill
li Lilly and Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of tumors in patients with an advanced form of the disease.
Community makes latest push into oncology with $60M cancer center
Community Health Network’s new Cancer Center North, which will have its grand opening Saturday is designed to lift patients’ spirits as much as kill cancer cells.
Cancer often comes down to random chance, study says
Lifestyle and heredity get the most blame for cancer, but new research suggests random chance plays a bigger role than people realize.
Chinese firm working with Lilly gets positive results on cancer drug
Hutchison China MediTech Ltd., the biotechnology company that has a partnership with Eli Lilly and Co., on Friday reported positive late-stage results for its drug to treat colorectal cancer.
Purdue-based firm could change radiation treatments
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
Lilly shares rise after Alimta cancer drug patent upheld on appeal
Teva Pharmaceuticals Industries Ltd.’s proposed generic version infringes a patent on the multi-billion-dollar patent, the U.S. Court of Appeals for the Federal Circuit ruled.
My body is the battleground between cancer and chemo
The point of chemo is to cure me. But these are not gentle chemicals. They sweep through my body like a tornado, with side effects that range from annoying to horrendous. But I have no choice.